Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001504964 | SCV001709852 | likely benign | not provided | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001504964 | SCV002546791 | uncertain significance | not provided | 2022-01-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV003346586 | SCV004061596 | uncertain significance | Inborn genetic diseases | 2023-08-22 | criteria provided, single submitter | clinical testing | The c.2432A>G (p.K811R) alteration is located in exon 8 (coding exon 7) of the WFS1 gene. This alteration results from a A to G substitution at nucleotide position 2432, causing the lysine (K) at amino acid position 811 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038242 | SCV005667573 | uncertain significance | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2024-01-05 | criteria provided, single submitter | clinical testing |